| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), CBUS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 894.3K | $1.62M | - | |
| CEO | 686.8K | $1.24M | - | |
| VP | 422.9K | $765.4K | - | |
| Other | 167.9K | $303.8K | - | |
| CFO | 154.3K | $279.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,083 | $13.84 | $56,514.44 | -4.2% | |
| Oct 5, 2018 | Dumont Philippe | Director | Sell | 1,117 | $14.11 | $15,765.23 | -5.8% | |
| Oct 1, 2018 | Sahoo Manoj | Chief Commercial Officer | Sell | 2,521 | $14.84 | $37,416.18 | -3.1% | |
| Sep 20, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,666 | $16.00 | $74,656.00 | -4.8% | |
| Sep 10, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,083 | $16.13 | $65,842.05 | -4.2% | |
| Aug 20, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,666 | $17.31 | $80,768.46 | -4.8% | |
| Aug 8, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,083 | $17.48 | $71,372.47 | -4.2% | |
| Jul 20, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,666 | $17.94 | $83,708.04 | -4.8% | |
| Jul 9, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,083 | $17.84 | $72,822.35 | -4.2% | |
| Jun 21, 2018 | Godard Alain | Director | Sell | 5,880 | $20.84 | $122,540.38 | -15.0% |